Clover Health Investments Return on Tangible Equity 2020-2025 | CLOV
Current and historical return on tangible equity values for Clover Health Investments (CLOV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Clover Health Investments Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.03B | $0.33B | -7.51% |
| 2024-12-31 | $-0.04B | $0.34B | -13.35% |
| 2024-09-30 | $-0.09B | $0.34B | -29.52% |
| 2024-06-30 | $-0.12B | $0.32B | -41.10% |
| 2024-03-31 | $-0.16B | $0.29B | -53.63% |
| 2023-12-31 | $-0.21B | $0.28B | -71.00% |
| 2023-09-30 | $-0.23B | $0.30B | -72.41% |
| 2023-06-30 | $-0.26B | $0.31B | -77.97% |
| 2023-03-31 | $-0.34B | $0.30B | -92.63% |
| 2022-12-31 | $-0.34B | $0.34B | -82.74% |
| 2022-09-30 | $-0.44B | $0.39B | -96.29% |
| 2022-06-30 | $-0.40B | $0.42B | -86.61% |
| 2022-03-31 | $-0.62B | $0.49B | -141.38% |
| 2021-12-31 | $-0.59B | $0.54B | -127.90% |
| 2021-09-30 | $-0.53B | $0.41B | -306.84% |
| 2021-06-30 | $-0.48B | $0.31B | -674.65% |
| 2021-03-31 | $-0.16B | $0.59B | 2836.36% |
| 2020-12-31 | $-0.14B | $-0.62B | 89.62% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.333B | $1.371B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.621B | 58.04 |
| Tempus AI (TEM) | United States | $12.054B | 0.00 |
| Doximity (DOCS) | United States | $12.025B | 53.35 |
| Hims & Hers Health (HIMS) | United States | $10.818B | 89.50 |
| IRhythm Technologies (IRTC) | United States | $5.361B | 0.00 |
| Hinge Health (HNGE) | United States | $4.529B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.584B | 37.98 |
| Privia Health (PRVA) | United States | $2.580B | 191.09 |
| Phreesia (PHR) | United States | $1.705B | 0.00 |
| Enovis (ENOV) | United States | $1.691B | 8.94 |
| 10x Genomics (TXG) | United States | $1.671B | 0.00 |
| Azenta (AZTA) | United States | $1.471B | 64.16 |
| Schrodinger (SDGR) | United States | $1.456B | 0.00 |
| Omnicell (OMCL) | United States | $1.440B | 27.74 |
| Claritev (CTEV) | United States | $1.157B | 0.00 |
| Evolent Health (EVH) | United States | $1.053B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.666B | 0.00 |
| Veradigm (MDRX) | United States | $0.509B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.504B | 0.00 |
| Standard BioTools (LAB) | United States | $0.498B | 0.00 |
| Talkspace (TALK) | United States | $0.432B | 129.00 |
| Carlsmed (CARL) | $0.365B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.357B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.66 |
| Outset Medical (OM) | United States | $0.235B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.227B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.210B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.199B | 0.00 |
| CapsoVision (CV) | United States | $0.189B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.130B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.108B | 4.90 |
| EUDA Health Holdings (EUDA) | Singapore | $0.095B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.070B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.019B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |